Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry

Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry

Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized disease that often results in heart failure and death. Traditionally, biological staging systems are used to stratify disease severity. Reduced aerobic capacity has recently been described as useful in identifying higher risk...

Full description

Bibliographic Details
Main Authors: Rishika Banydeen, Reid Eggleston, Antoine Deney, Astrid Monfort, Jay H. Ryu, Giuseppe Vergaro, Vincenzo Castiglione, Olivier Lairez, Michele Emdin, Jocelyn Inamo, Misbah Baqir, Remi Neviere
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Journal of Clinical Medicine
Subjects:
transthyretin cardiac amyloidosis
prognosis
forced vital capacity
lung volume restriction
cardiopulmonary exercise
biomarker staging
Online Access:https://www.mdpi.com/2077-0383/12/11/3684

Internet

https://www.mdpi.com/2077-0383/12/11/3684

Similar Items